[Treatment of recurrent neovascular age-related macular degeneration with ranibizumab according to the PrONTO scheme].;Rezidivbehandlung der neovaskulären altersbedingten Makuladegeneration mit Ranibizumab nach dem PrONTO-Schema.

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft

Volumn 110, Issue 8, 2013, Pages 740-745

  Wolf, A ^a   Reznicek, L ^b   Muhr, J ^b   Ulbig, M ^b   Kampik, A ^b   Haritoglou, C ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; RANIBIZUMAB;

AGED; COMPLICATION; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SECONDARY PREVENTION; TREATMENT OUTCOME; VERY ELDERLY; VISION DISORDERS; VISUAL ACUITY; WET MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; TREATMENT OUTCOME; VISION DISORDERS; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84895844792     PISSN: None     EISSN: 14330423     Source Type: Journal    
DOI: 10.1007/s00347-012-2717-6     Document Type: Article

References (0)